Efficacy and Safety of Atropine and Orthokeratology Lens in Delaying Juvenile Myopia
Key Findings:
A study investigated the effectiveness and safety of combining low-concentration Atropine with orthokeratology (OK) lens in delaying juvenile myopia. The study included 172 adolescents aged 8 to 12 years over a period from April 2021 to May 2022.
The results showed that the combination of low-concentration Atropine with OK lens effectively delayed the development of juvenile myopia and demonstrated high safety. Additionally, the combination treatment had a lower probability of postoperative adverse reactions compared to other treatment methods.
Furthermore, the study found that low-concentration Atropine did not significantly impact basic tear secretion and tear film stability, while nightwear of OK lens had no significant impact but reduced the tear film rupture time in the first 3 months, with no long-term impact on tear film rupture time.
Practical Solutions and Value:
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into a single, easily accessible knowledge base for clinicians, helping to extend the benefits of clinical trials into everyday medical practice.
In the current healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally, ultimately improving patient outcomes and reducing paper routines.
By leveraging AI, clinics can enhance their workflows and improve patient outcomes. Learn more about how we can help at aidevmd.com.
